Since the earliest days of the pandemic, a quiet mystery has persisted alongside the crisis itself: a portion of humanity, repeatedly exposed to SARS-CoV-2, has never fallen ill. Scientists now turn their gaze inward — toward genetics, cellular memory, and the immunological echoes of past infections — seeking to understand whether some people carry an ancient biological shield or have simply been touched by fortune. The answer, still elusive, reminds us that human vulnerability is never uniform, and that the body's relationship with disease is written in a language science is only beginning to
infobae
· Aug 15, 2022
· health
· 5 min read
Medium
Sourcing: Characterized
Genetics, vaccination or luck: Why some people never caught COVID-19
◉
Health & Medicine
2798 related articles
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% match
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% match
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% match
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% match
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% match
Related Coverage
El País · Aug 22
La personalidad Ozempic: cómo la delgadez extrema acaba con el placer
Usuarios de fármacos GLP-1 como Ozempic reportan anhedonia, un efecto secundario que les impide disfrutar de actividades…
CNN en Español · Aug 22 Moderna y Merck logran avance decisivo con vacuna personalizada contra el cáncerMerck y Moderna reportan éxito de una vacuna personalizada contra el melanoma que entrena el sistema inmunológico para a…
El Divisadero · Aug 21 Hepatitis virales: herramientas de prevención y cura al alcance en AysénGastroenterólogo del Hospital Regional Coyhaique explica las hepatitis virales, sus formas de transmisión y las herramie…
radiosantamaria.cl · Aug 21 Escuela España suspende clases por brote de enfermedades respiratorias en CoyhaiqueLa Escuela Diferencial España de Coyhaique suspendió clases por 48 horas tras confirmarse un brote de enfermedades respi…
Bias & Framing
⚖
Article presents balanced scientific inquiry into COVID-19 immunity with minimal bias, though framing emphasizes luck and anecdotal accounts alongside genetic factors.
Bias Direction
center
Confidence
MED
The article frames the phenomenon as a mystery ('one of science's greatest questions') and balances scientific explanations (genetics, immunity, vaccination) with anecdotal personal narratives and luck-based interpretations, creating a somewhat sensationalized but not overtly partisan presentation.
afortunados (fortunate/lucky)
esquivado la enfermedad (dodged the disease)
Me resulta curioso (I find it curious)
lo más normal posible (as normal as possible)
Epidemiologists discussing population-level immunity thresholds
Public health officials on asymptomatic infection rates
Perspectives from immunocompromised individuals
Discussion of testing limitations and false negatives
Expert commentary on the reliability of self-reported non-infection
Geopolitical Impact
🌎
Scientific investigation into why some individuals remain uninfected despite COVID-19 exposure reveals genetic, immunological, and behavioral factors rather than geopolitical significance.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Scientific investigation into COVID-19 immunity reveals genetic factors, vaccination, and cross-immunity as explanations for uninfected populations, with ~57% of Americans never infected despite exposure.
Market Signal
neutral
Confidence
MED
Healthcare and pharmaceuticals
Public health services
Medical research and biotechnology
Insurance and risk assessment
Travel and hospitality
Consumers may adjust health insurance decisions and travel behavior based on personal infection risk perception. Those with genetic protection may reduce preventive spending, while others may increase health monitoring and insurance coverage.
Governments may shift pandemic response strategies from universal prevention to risk-stratified approaches. Public health agencies could develop genetic screening programs and personalized vaccination recommendations. Insurance models may incorporate genetic risk factors, raising ethical and regulatory concerns.